APYX vs MS · rev $48.1M vs P/E 20, $344.27B cap
Apyx Medical Inc (APYX) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
MS does not have a complete income-statement cache yet.
APYX currently screens at market cap $179.6M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the APYX and MS stock pages for the full models.
Not investment advice.